About this Journal Submit a Manuscript Table of Contents

Citations to this Journal [1,268 citations: 1–100 of 1,202 articles]

Articles published in Advances in Hematology have been cited 1,268 times. The following is a list of the 1,202 articles that have cited the articles published in Advances in Hematology.

  • Arshpreet Kaur, and Asha Thomas, “Diffuse Large B-Cell Lymphoma Presenting with Diabetes Insipidus: A Case Report,” AACE Clinical Case Reports, vol. 1, no. 2, pp. e111–e114, 2015. View at Publisher · View at Google Scholar
  • Jia Wei, Jinhuan Xu, Yang Cao, Jianfeng Zhou, and Yicheng Zhang, “Allogeneic Stem-Cell Transplantation for Peripheral T-Cell Lymphoma: A Systemic Review and Meta-Analysis,” Acta Haematologica, vol. 133, no. 2, pp. 136–144, 2015. View at Publisher · View at Google Scholar
  • X.-F. Lin, X.-L. Ten, X.-B. Tang, and J. Chen, “Serum soluble CD40 ligand levels after acute intracerebral hemorrhage,” Acta Neurologica Scandinavica, 2015. View at Publisher · View at Google Scholar
  • Michael T. Schmidt, Qin Huang, and Serhan Alkan, “Aggressive B-Cell Lymphomas,” Advances In Anatomic Pathology, vol. 22, no. 3, pp. 168–180, 2015. View at Publisher · View at Google Scholar
  • Arunima Ghosh, Andy Vo, Beverly K. Twiss, Colin A. Kretz, Mary A. Jozwiak, Robert R. Montgomery, and Jordan A. Shavit, “Corrigendum to “Characterization of Zebrafish von Willebrand Factor Reveals Conservation of Domain Structure, Multimerization, and Intracellular Storage”,” Advances in Hematology, vol. 2015, pp. 1–1, 2015. View at Publisher · View at Google Scholar
  • Felix Keil, George L. Daikos, Athanasios Skoutelis, Jose Ignacio Barranco Dominguez, Rashidkhan Pathan, and Kamal Hamed, “Daptomycin for Gram-positive Infections in Patients with Neutropenia: Clinical Experience from a European Outcomes Registry,” Advances in Therapy, 2015. View at Publisher · View at Google Scholar
  • Maria Joao Baptista, Olga Garcia, Mireia Morgades, Eva Gonzalez-Barca, Pilar Miralles, Armando Lopez-Guillermo, Eugenia Abella, Miriam Moreno, Juan-Manuel Sancho, Evarist Feliu, Josep-Maria Ribera, and Jose-Tomas Navarro, “HIV-infection impact on clinical–biological features and outcome of diffuse large B-cell lymphoma treated with R-CHOP in the combination antiretroviral therapy era,” Aids, vol. 29, no. 7, pp. 811–818, 2015. View at Publisher · View at Google Scholar
  • S. Imbesi, A. Allegra, G. Calapai, C. Musolino, and S. Gangemi, “Cutaneous adverse reactions to lenalidomide,” Allergologia et Immunopathologia, vol. 43, no. 1, pp. 88–91, 2015. View at Publisher · View at Google Scholar
  • Valentina Nardi, Olja Pulluqi, Jeremy S. Abramson, Paola Dal Cin, and Robert P. Hasserjian, “Routine conventional karyotyping of lymphoma staging bone marrow samples does not contribute clinically relevant information,” American Journal of Hematology, 2015. View at Publisher · View at Google Scholar
  • Z. Xu, D. Nayak, W. Yang, G. Baskaran, S. Ramachandran, N. Sarma, A. Aloush, E. Trulock, R. Hachem, G. A. Patterson, and T. Mohanakumar, “Dysregulated MicroRNA Expression and Chronic Lung Allograft Rejection in Recipients With Antibodies to Donor HLA,” American Journal Of Transplantation, vol. 15, no. 7, pp. 1933–1947, 2015. View at Publisher · View at Google Scholar
  • Ademola Samson Adewoyin, “Management of Sickle Cell Disease: A Review for Physician Education in Nigeria (Sub-Saharan Africa),” Anemia, vol. 2015, pp. 1–21, 2015. View at Publisher · View at Google Scholar
  • Massimo Breccia, Maria Teresa Voso, Maria Antonietta Aloe Spiriti, Susanna Fenu, Luca Maurillo, Francesco Buccisano, Agostino Tafuri, and Giuliana Alimena, “An increase in hemoglobin, platelets and white blood cells levels by iron chelation as single treatment in multitransfused patients with myelodysplastic syndromes: clinical evidences and possible biological mechanisms,” Annals of Hematology, vol. 94, no. 5, pp. 771–777, 2015. View at Publisher · View at Google Scholar
  • Renuka Palani, Dragana Milojkovic, and Jane F. Apperley, “Managing pregnancy in chronic myeloid leukaemia,” Annals of Hematology, vol. 94, no. S2, pp. 167–176, 2015. View at Publisher · View at Google Scholar
  • Susanne Radonjic-Hoesli, Peter Valent, Amy D. Klion, Michael E. Wechsler, and Hans-Uwe Simon, “Novel Targeted Therapies for Eosinophil-Associated Diseases and Allergy,” Annual Review of Pharmacology and Toxicology, vol. 55, no. 1, pp. 633–656, 2015. View at Publisher · View at Google Scholar
  • Tanja Pozzuto, Carsten Röger, Jens Kurreck, and Henry Fechner, “Enhanced suppression of adenovirus replication by triple combination of anti-adenoviral siRNAs, soluble adenovirus receptor trap sCAR-Fc and cidofovir,” Antiviral Research, vol. 120, pp. 72–78, 2015. View at Publisher · View at Google Scholar
  • Dennis P. O'Malley, Aaron Auerbach, and Lawrence M. Weiss, “Practical Applications in Immunohistochemistry: Evaluation of Diffuse Large B-Cell Lymphoma and Related Large B-Cell Lymphomas,” Archives of Pathology & Laboratory Medicine, vol. 139, no. 9, pp. 1094–1107, 2015. View at Publisher · View at Google Scholar
  • Haiyan Xue, Kunping Yan, Xiufang Zhao, Wenjin Zhu, Lijun Liu, Zhilan Xie, Hongli Zhu, and Chao Chen, “ Pretreatment with pPolyHb attenuates H 2 O 2 -induced endothelial cell injury through inhibition of JNK/p38 MAPK pathway by upregulation of heme oxygenase-1 ,” Artificial Cells, Nanomedicine, and Biotechnology, pp. 1–11, 2015. View at Publisher · View at Google Scholar
  • Christian Bleilevens, Oliver Grottke, Sabine Tillmann, Markus Honickel, RüEdger Kopp, Jutta Arens, and Rolf Rossaint, “Twelve Hours In Vitro Biocompatibility Testing of Membrane Oxygenators,” ASAIO Journal, vol. 61, no. 5, pp. 548–555, 2015. View at Publisher · View at Google Scholar
  • Beverly A. Teicher, and Joseph E. Tomaszewski, “Proteasome Inhibitors,” Biochemical Pharmacology, 2015. View at Publisher · View at Google Scholar
  • Emyr Bakker, Malak Qattan, Luciano Mutti, Constantinos Demonacos, and Marija Krstic-Demonacos, “The Role of Microenvironment and Immunity in Drug Response in Leukemia,” Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2015. View at Publisher · View at Google Scholar
  • Vemika Chandra, Ella Bhagyaraj, Raman Parkesh, and Pawan Gupta, “Transcription factors and cognate signalling cascades in the regulation of autophagy,” Biological Reviews, 2015. View at Publisher · View at Google Scholar
  • Şahika Zeynep Akı, Elif Suyanı, Mustafa Cengiz, Seren Özenirler, Şehri Elbeğ, Hatice Paşaoğlu, and Gülsan Türköz Sucak, “Association between Plasma Endothelin-1, Transforming Growth Factor-β, Fibroblast Growth Factor, and Nitric Oxide Levels and Liver Injury in Hematopoietic Stem Cell Transplantation Recipients with Persistent Iron Overload after Transplantation,” Biology of Blood and Marrow Transplantation, 2015. View at Publisher · View at Google Scholar
  • Ian B. Copland, Muna Qayed, Marco A. Garcia, Jacques Galipeau, and Edmund K. Waller, “Bone Marrow Mesenchymal Stromal Cells from Patients with Acute and Chronic Graft-versus-Host Disease Deploy Normal Phenotype, Differentiation Plastici,” Biology Of Blood And Marrow Transplantation, vol. 21, no. 5, pp. 934–953, 2015. View at Publisher · View at Google Scholar
  • Claire Calmettes, Stéphane Vigouroux, Myriam Labopin, Reza Tabrizi, Pascal Turlure, Xavier Lafarge, Gérald Marit, Arnaud Pigneux, Thibaut Leguay, Krimo Bouabdallah, Marie-Sarah Dilhuydy, Cédric Duclos, Catherine Mohr, Axelle Lascaux, Pierre-Yves Dumas, Sophie Dimicoli-Salazar, Arnaud Saint-Lézer, and Noël Milpied, “Risk Factors for Steroid-Refractory Acute Graft-versus-Host Disease after Allogeneic Stem Cell Transplantation from Matched Related or Unrelated Donors,” Biology of Blood and Marrow Transplantation, 2015. View at Publisher · View at Google Scholar
  • Egil S. Blix, Anders B. Kildal, Eirin Bertelsen, Anders Waage, June H. Myklebust, Arne Kolstad, and Anne Husebekk, “Content of Endothelial Progenitor Cells in Autologous Stem Cell Grafts Predict Survival after Transplantation for Multiple Myeloma,” Biology of Blood and Marrow Transplantation, 2015. View at Publisher · View at Google Scholar
  • Elisabetta Calore, Piero Marson, Marta Pillon, Manuela Tumino, Tiziana Tison, Chiara Mainardi, Giustina De Silvestro, Sara Rossin, Genny Franceschetto, Elisa Carraro, Matilde Pescarin, Stefania Varotto, Roberta Destro, Maria Vittoria Gazzola, Giuseppe Basso, and Chiara Messina, “Treatment of Acute Graft-versus-Host Disease in Childhood with Extracorporeal Photochemotherapy/Photopheresis: The Padova Experience,” Biology of Blood and Marrow Transplantation, 2015. View at Publisher · View at Google Scholar
  • Alix O'Meara, Wahid Boukouaci, Marie Robin, Aliénor Xhaard, Catherine Fortier, François Marzais, Flore Sicre de Fontbrune, Régis Peffault de Latour, Dominique Charron, Gerard Socié, and Ryad Tamouza, “GLCCI1 and Glucocorticoid Receptor Genetic Diversity and Response to Glucocorticoid-Based Treatment of Graft-versus-Host Disease,” Biology of Blood and Marrow Transplantation, 2015. View at Publisher · View at Google Scholar
  • Joseph G Taylor, Konstantinos Liapis, and John G Gribben, “The role of the tumor microenvironment in HIV-associated lymphomas,” Biomarkers in Medicine, vol. 9, no. 5, pp. 473–482, 2015. View at Publisher · View at Google Scholar
  • Seyed Ali Mousavi, Faiza Mahmood, Astrid Aandahl, Teresa Risopatron Knutsen, and Abid Hussain Llohn, “ Relationship of Baseline Hemoglobin Level with Serum Ferritin, Postphlebotomy Hemoglobin Changes, and Phlebotomy Requirements among HFE C282Y Homozygotes ,” BioMed Research International, vol. 2015, pp. 1–9, 2015. View at Publisher · View at Google Scholar
  • Abuzar Elnager, Rosline Hassan, Zamzuri Idris, Zulkifli Mustafa, Nadiah Wan-Arfah, S. A. Sulaiman, Siew Hua Gan, and Wan Zaidah Abdullah, “ Fibrinolytic Activity and Dose-Dependent Effect of Incubating Human Blood Clots in Caffeic Acid Phenethyl Ester: In Vitro Assays ,” BioMed Research International, vol. 2015, pp. 1–10, 2015. View at Publisher · View at Google Scholar
  • L. I. Nagy, L. Z. Fehér, G. J. Szebeni, M. Gyuris, P. Sipos, R. Alföldi, B. Ózsvári, L. Hackler, A. Balázs, P. Batár, I. Kanizsai, and L. G. Puskás, “Curcumin and Its Analogue Induce Apoptosis in Leukemia Cells and Have Additive Effects with Bortezomib in Cellular and Xenograft Models,” BioMed Research International, vol. 2015, pp. 1–11, 2015. View at Publisher · View at Google Scholar
  • Wenjing Bao, Mei Gao, Yanyan Cheng, Hyun Jae Lee, Qinghao Zhang, Susan Hemingway, Zhibo Luo, Andrzej Krol, Guanlin Yang, and Jing An, “ Biomodification of PCL Scaffolds with Matrigel, HA, and SR1 Enhances De Novo Ectopic Bone Marrow Formation Induced by rhBMP-2 ,” BioResearch Open Access, pp. 298–306, 2015. View at Publisher · View at Google Scholar
  • Greg Hapgood, and Kerry J. Savage, “The biology and management of systemic anaplastic large cell lymphoma,” Blood, vol. 126, no. 1, pp. 17–25, 2015. View at Publisher · View at Google Scholar
  • R. C. Lynn, M. Poussin, A. Kalota, Y. Feng, P. S. Low, D. S. Dimitrov, and D. J. Powell, “Targeting of folate receptor   on acute myeloid leukemia blasts with chimeric antigen receptor-expressing T cells,” Blood, vol. 125, no. 22, pp. 3466–3476, 2015. View at Publisher · View at Google Scholar
  • Laurie H. Sehn, and Randy D. Gascoyne, “Diffuse large B-cell lymphoma: optimizing outcome in the context of clinical and biologic heterogeneity,” Blood, vol. 125, no. 1, pp. 22–32, 2015. View at Publisher · View at Google Scholar
  • Xiangguo Shi, Bai-Liang He, Alvin C. H. Ma, Yuhan Guo, Yali Chi, Cheuk Him Man, Wenqing Zhang, Yiyue Zhang, Zilong Wen, Tao Cheng, and Anskar Y. H. Leung, “Functions of idh1 and its mutation in the regulation of developmental hematopoiesis in zebrafish,” Blood, vol. 125, no. 19, pp. 2974–2984, 2015. View at Publisher · View at Google Scholar
  • Andre Weilemann, Michael Grau, Tabea Erdmann, Olaf Merkel, Ulduz Sobhiafshar, Ioannis Anagnostopoulos, Michael Hummel, Antje Siegert, Claudia Hayford, Hannelore Madle, Brigitte Wollert-Wulf, Iduna Fichtner, Bernd Doerken, Stephan Dirnhofer, Stephan Mathas, Martin Janz, N. C. Tolga Emre, Andreas Rosenwald, German Ott, Peter Lenz, Alexandar Tzankov, and Georg Lenz, “Essential role of IRF4 and MYC signaling for survival of anaplastic large cell lymphoma,” Blood, vol. 125, no. 1, pp. 124–132, 2015. View at Publisher · View at Google Scholar
  • P. Prakash, P. P. Kulkarni, S. R. Lentz, and A. K. Chauhan, “Cellular fibronectin containing extra domain A promotes arterial thrombosis in mice through platelet Toll-like receptor 4,” Blood, vol. 125, no. 20, pp. 3164–3172, 2015. View at Publisher · View at Google Scholar
  • Rekha Athiyarath, Biju George, Aby Abraham, Auro Viswabandya, Alok Srivastava, and Eunice Sindhuvi Edison, “Genetic modifiers of secondary iron overload in beta thalassemia major,” Blood Cells, Molecules, and Diseases, 2015. View at Publisher · View at Google Scholar
  • Jae-Hoon Lee, Kihyun Kim, Jin Seok Kim, Je-Jung Lee, Soo-Mee Bang, Chang-Ki Min, Joon Seong Park, Hyo Jung Kim, Sung-Soo Yoon, and Hyeon Seok Eom, “Use of lenalidomide in the management of relapsed or refractory multiple myeloma: expert recommendations in Korea,” Blood Research, vol. 50, no. 1, pp. 7, 2015. View at Publisher · View at Google Scholar
  • K.M. Kortüm, Y.X. Zhu, C.X. Shi, P. Jedlowski, and A.K. Stewart, “Cereblon binding molecules in multiple myeloma,” Blood Reviews, 2015. View at Publisher · View at Google Scholar
  • Kaixiong Ye, Chang Cao, Xu Lin, Kimberly O. O'Brien, and Zhenglong Gu, “Natural selection on HFE in Asian populations contributes to enhanced non-heme iron absorption,” Bmc Genetics, vol. 16, 2015. View at Publisher · View at Google Scholar
  • Catherine A. Guenther, Zhen Wang, Emma Li, Misha C. Tran, Catriona Y. Logan, Roel Nusse, Luiz Pantalena-Filho, George P. Yang, and David M. Kingsley, “A distinct regulatory region of the Bmp5 locus activates gene expression following adult bone fracture or soft tissue injury,” Bone, 2015. View at Publisher · View at Google Scholar
  • N Alam, W Xu, E G Atenafu, J Uhm, M Seftel, V Gupta, J Kuruvilla, J H Lipton, H A Messner, and D D H Kim, “Risk model incorporating donor IL6 and IFNG genotype and gastrointestinal GVHD can discriminate patients at high risk of steroid refractory acute GVHD,” Bone Marrow Transplantation, 2015. View at Publisher · View at Google Scholar
  • T Sauer, G Silling, C Groth, F Rosenow, U Krug, D Görlich, G Evers, J Albring, R Besoke, R M Mesters, C Müller-Tidow, T Kessler, T Büchner, W E Berdel, and M Stelljes, “Treatment strategies in patients with AML or high-risk myelodysplastic syndrome relapsed after Allo-SCT,” Bone Marrow Transplantation, 2015. View at Publisher · View at Google Scholar
  • H. Xiong, X. Y. Yang, J. Han, Q. Wang, and Z. L. Zou, “Cytokine expression patterns and mesenchymal stem cell karyotypes from the bone marrow microenvironment of patients with myelodysplastic syndromes,” Brazilian Journal Of Medical And Biological Research, vol. 48, no. 3, pp. 207–213, 2015. View at Publisher · View at Google Scholar
  • Min-Ki Seong, Ju-Young Lee, Jangmoo Byeon, Yeun-Ju Sohn, Hyesil Seol, Jin-Kyung Lee, Eun-Kyu Kim, Hyun-Ah Kim, and Woo Chul Noh, “Bcl-2 is a highly significant prognostic marker of hormone-receptor-positive, human epidermal growth factor receptor-2-negative breast cancer,” Breast Cancer Research And Treatment, vol. 150, no. 1, pp. 141–148, 2015. View at Publisher · View at Google Scholar
  • Bruce Shiramizu, Stanton Goldman, Lynette Smith, Melissa Agsalda-Garcia, Paul Galardy, Sherrie L. Perkins, J. Kimble Frazer, Warren Sanger, James R. Anderson, Thomas G. Gross, Howard Weinstein, Lauren Harrison, Matthew J. Barth, Lara Mussolin, and Mitchell S. Cairo, “Impact of persistent minimal residual disease post-consolidation therapy in children and adolescents with advanced Burkitt leukaemia: a Children's Oncology Group Pilot Study Report,” British Journal of Haematology, 2015. View at Publisher · View at Google Scholar
  • Simona Conte, Shintaro Katayama, Liselotte Vesterlund, Mohsen Karimi, Marios Dimitriou, Monika Jansson, Teresa Mortera-Blanco, Per Unneberg, Elli Papaemmanuil, Birgitta Sander, Tiina Skoog, Peter Campbell, Julian Walfridsson, Juha Kere, and Eva Hellström-Lindberg, “ Aberrant splicing of genes involved in haemoglobin synthesis and impaired terminal erythroid maturation in SF3B1 mutated refractory anaemia with ring sideroblasts ,” British Journal of Haematology, 2015. View at Publisher · View at Google Scholar
  • Adam J. Olszewski, Rajesh Shrestha, and Nathaniel M. Cook, “Race-specific features and outcomes of nodular lymphocyte-predominant Hodgkin lymphoma: Analysis of the National Cancer Data Base,” Cancer, 2015. View at Publisher · View at Google Scholar
  • Francis R LeBlanc, Xin Liu, Jeremy Hengst, Todd Fox, Valerie Calvert, Emanuel F Petricoin, Jong Yun, David J Feith, and Thomas P. Loughran, “Sphingosine kinase inhibitors decrease viability and induce cell death in natural killer-large granular lymphocyte leukemia,” Cancer Biology & Therapy, pp. 00–00, 2015. View at Publisher · View at Google Scholar
  • Aparna Vasanthakumar, and Lucy A. Godley, “5-hydroxymethylcytosine in cancer: significance in diagnosis and therapy,” Cancer Genetics, vol. 208, no. 5, pp. 167–177, 2015. View at Publisher · View at Google Scholar
  • Renata Binato, Nathalia Correa de Almeida Oliveira, Barbara Du Rocher, and Eliana Abdelhay, “The molecular signature of AML mesenchymal stromal cells reveals candidate genes related to the leukemogenic process,” Cancer Letters, 2015. View at Publisher · View at Google Scholar
  • Maria Raffaella Petrara, Silvia Giunco, Diego Serraino, Riccardo Dolcetti, and Anita De Rossi, “Post-transplant lymphoproliferative disorders: from epidemiology to pathogenesis-driven treatment,” Cancer Letters, 2015. View at Publisher · View at Google Scholar
  • Nils H. Nicolay, Ramon Lopez Perez, Juergen Debus, and Peter E. Huber, “Mesenchymal stem cells – a new hope for radiotherapy-induced tissue damage?,” Cancer Letters, 2015. View at Publisher · View at Google Scholar
  • Matteo Lambertini, Fedro A. Peccatori, and Hatem A. Azim, “Targeted agents for cancer treatment during pregnancy,” Cancer Treatment Reviews, 2015. View at Publisher · View at Google Scholar
  • Mahakit Inklab, Richard H. Steingart, and Jonathan K. Freeman, “Primary Lymphoma of Bone Presenting as Spindle Cell Neoplasm of the Vertebral Body: A Case Report and Review of the Literature,” Case Reports in Hematology, vol. 2015, pp. 1–4, 2015. View at Publisher · View at Google Scholar
  • Harpreet Kochhar, Chantal S. Leger, and Heather A. Leitch, “Durable Red Blood Cell Transfusion Independence in a Patient with an MDS/MPN Overlap Syndrome Following Discontinuation of Iron Chelation Therapy,” Case Reports in Hematology, vol. 2015, pp. 1–7, 2015. View at Publisher · View at Google Scholar
  • Ahmad Ahmadzadeh, Richard E. Kast, Neda Ketabchi, Saeid Shahrabi, Mohammad Shahjahani, Kaveh Jaseb, and Najmaldin Saki, “Regulatory effect of chemokines in bone marrow niche,” Cell and Tissue Research, 2015. View at Publisher · View at Google Scholar
  • Srividya Bhaskara, “Histone Deacetylases 1 and 2 Regulate DNA replication and DNA repair: Potential Targets for Genome Stability-Mechanism–Based Therapeutics for a Subset of Cancers,” Cell Cycle, pp. 00–00, 2015. View at Publisher · View at Google Scholar
  • Jean-Marc Doisne, Christian M. Hüber, Klaus Okkenhaug, and Francesco Colucci, “Immunomodulation of Selective Naive T Cell Functions by p110δ Inactivation Improves the Outcome of Mismatched Cell Transplantation,” Cell Reports, 2015. View at Publisher · View at Google Scholar
  • Babak Beikzadeh, and Nowruz Delirezh, “Phenotypic and functional comparison of two distinct subsets of programmable cell of monocytic origin (PCMOs)-derived dendritic cells with conventional monocyte-derived dendritic cells,” Cellular and Molecular Immunology, 2015. View at Publisher · View at Google Scholar
  • Hong-Wei Fan, Fu-Ping Guo, Yi-Jia Li, Ning Li, and Tai-Sheng Li, “Prevalence of Thrombocytopenia among Chinese Adult Antiretroviral-naive HIV-positive Patients,” Chinese Medical Journal, vol. 128, no. 4, pp. 459–464, 2015. View at Publisher · View at Google Scholar
  • Si Zhang, Shenghui Zhang, Liang Hu, Lili Zhai, Ruyi Xue, Jianqin Ye, Leilei Chen, Guanjun Cheng, Jozef Mruk, Satya P. Kunapuli, and Zhongren Ding, “Nucleotide-Binding Oligomerization Domain 2 Receptor Is Expressed in Platelets and Enhances Platelet Activation and Thrombosis,” Circulation, vol. 131, no. 13, pp. 1160–+, 2015. View at Publisher · View at Google Scholar
  • Jian Zhang, Xiao-Hua Yu, Yi-Guo Yan, Cheng Wang, and Wen-Jun Wang, “PI3K/Akt signaling in osteosarcoma,” Clinica Chimica Acta, 2015. View at Publisher · View at Google Scholar
  • Juan I. Arcelus, Pere Domenech, Ma del Carmen Fernandez-Capitan, Ricardo Guijarro, David Jimenez, Sonia Jimenez, Francisco S. Lozano, Manel Monreal, Jose A. Nieto, and Jose A. Paramo, “Rivaroxaban in the Treatment of Venous Thromboembolism and the Prevention of Recurrences: A Practical Approach,” Clinical And Applied Thrombosis-Hemostasis, vol. 21, no. 4, pp. 297–308, 2015. View at Publisher · View at Google Scholar
  • Andrea Thives de Carvalho Hoepers, Marcia Margarete Menezes, and Tânia Silvia Fröde, “Systematic review of anaemia and inflammatory markers in chronic obstructive pulmonary disease,” Clinical and Experimental Pharmacology and Physiology, vol. 42, no. 3, pp. 231–239, 2015. View at Publisher · View at Google Scholar
  • Joshua B. Ryan, Sandy J. Southby, Lesney A. Stuart, Christopher M. Florkowski, and Peter M. George, “Comparison of Abbott Architect high-sensitivity troponin I in Rapid Serum Tubes and plasma,” Clinical Chemistry And Laboratory Medicine, vol. 53, no. 1, pp. E1–E3, 2015. View at Publisher · View at Google Scholar
  • Marco Benati, Martina Montagnana, Elisa Danese, Giovanna De Matteis, Dino Veneri, Elisa Paviati, and Gian Cesare Guidi, “Role of JAK2 V617F mutation and aberrant expression of microRNA-143 in myeloproliferative neoplasms,” Clinical Chemistry And Laboratory Medicine, vol. 53, no. 7, pp. 1005–1011, 2015. View at Publisher · View at Google Scholar
  • Daniel H. Johnson, Thomas Reske, and Marco Ruiz, “Case Report and Review of Immunodeficiency Associated Burkitt Lymphoma,” Clinical Lymphoma Myeloma and Leukemia, 2015. View at Publisher · View at Google Scholar
  • Marcio M. Andrade-Campos, Anel E. Montes-Limón, Gloria Soro-Alcubierre, Luis López-Gómez, Teresa Baringo, and Pilar Giraldo, “Non-Hodgkin Lymphoma patients over 65 years old are suitable to treatment with 90Y-Ibritumumab Tiuxetan. Single-institution experience,” Clinical Lymphoma Myeloma and Leukemia, 2015. View at Publisher · View at Google Scholar
  • Antonio Del Vecchio, Mario Motta, and Costantino Romagnoli, “Neonatal Platelet Function,” Clinics in Perinatology, 2015. View at Publisher · View at Google Scholar
  • Lisanne M. van Leeuwen, Astrid M. van der Sar, and Wilbert Bitter, “Animal Models of Tuberculosis: Zebrafish,” Cold Spring Harbor Perspectives In Medicine, vol. 5, no. 3, 2015. View at Publisher · View at Google Scholar
  • Yoko Tabe, and Marina Konopleva, “Role of Microenvironment in Resistance to Therapy in AML,” Current Hematologic Malignancy Reports, 2015. View at Publisher · View at Google Scholar
  • Sarah A. Buckley, and Roland B. Walter, “Update on Antigen-Specific Immunotherapy of Acute Myeloid Leukemia,” Current Hematologic Malignancy Reports, 2015. View at Publisher · View at Google Scholar
  • Alberto Zanetto, Marco Senzolo, Alberto Ferrarese, Paolo Simioni, Patrizia Burra, and Kryssia I. Rodríguez-Castro, “Assessment of Bleeding Risk in Patients with Cirrhosis,” Current Hepatology Reports, 2015. View at Publisher · View at Google Scholar
  • D. Sanford, and C. C. Hsia, “A case of transfusion independence in a patient with myelodysplastic syndrome using deferasirox, sustained for two years after stopping therapy,” Current Oncology, vol. 22, no. 2, pp. E128–E132, 2015. View at Publisher · View at Google Scholar
  • Stephen M. Ansell, “Targeting immune checkpoints in lymphoma,” Current Opinion in Hematology, vol. 22, no. 4, pp. 337–342, 2015. View at Publisher · View at Google Scholar
  • Colin A. Kretz, Angela C. Weyand, and Jordan A. Shavit, “Modeling Disorders of Blood Coagulation in the Zebrafish,” Current Pathobiology Reports, 2015. View at Publisher · View at Google Scholar
  • Danny C. LeBert, Jayne M. Squirrell, Julie Rindy, Elizabeth Broadbridge, Yuming Lui, Anna Zakrzewska, Kevin W. Eliceiri, Annemarie H. Meijer, and Anna Huttenlocher, “Matrix metalloproteinase 9 modulates collagen matrices and wound repair,” Development, vol. 142, no. 12, pp. 2136–+, 2015. View at Publisher · View at Google Scholar
  • Inge R. Fink, Carla M.S. Ribeiro, Maria Forlenza, Anja Taverne-Thiele, Jan H.W.M. Rombout, Huub F.J. Savelkoul, and Geert F. Wiegertjes, “Immune-relevant thrombocytes of common carp undergo parasite-induced nitric oxide-mediated apoptosis,” Developmental & Comparative Immunology, 2015. View at Publisher · View at Google Scholar
  • Lisa Pleyer, and Richard Greil, “Digging deep into “dirty” drugs – modulation of the methylation machinery,” Drug Metabolism Reviews, pp. 1–28, 2015. View at Publisher · View at Google Scholar
  • Sonia Mercurio, Anna Aspesi, Lorenzo Silengo, Fiorella Altruda, Irma Dianzani, and Deborah Chiabrando, “Alteration of heme metabolism in a cellular model of Diamond-Blackfan anemia,” European Journal of Haematology, 2015. View at Publisher · View at Google Scholar
  • Christian Gisselbrecht, Fritz Offner, Jorge Romaguera, Lisa Kang, Pádraig J Moran, Georg Hess, Bertrand Coiffier, and Michael Crump, “Effect of prognostic classification on temsirolimus efficacy and safety in patients with relapsed or refractory mantle cell lymphoma: a retrospective analysis,” Experimental Hematology & Oncology, vol. 4, no. 1, 2015. View at Publisher · View at Google Scholar
  • Yao Yang, Joshua P Lewis, Jean-Sébastien Hulot, and Stuart A Scott, “ The pharmacogenetic control of antiplatelet response: candidate genes and CYP2C19 ,” Expert Opinion on Drug Metabolism & Toxicology, pp. 1–19, 2015. View at Publisher · View at Google Scholar
  • Dai Chihara, Loretta J Nastoupil, Jessica N Williams, Paul Lee, Jean L Koff, and Christopher R Flowers, “New insights into the epidemiology of non-Hodgkin lymphoma and implications for therapy,” Expert Review of Anticancer Therapy, pp. 1–14, 2015. View at Publisher · View at Google Scholar
  • Young Kim, and Ingo GH Schmidt-Wolf, “Lenalidomide in multiple myeloma,” Expert Review of Anticancer Therapy, pp. 1–7, 2015. View at Publisher · View at Google Scholar
  • Silvana Novelli, Jorge Sierra, and Javier Briones, “New therapies in non-Hodgkin lymphoma,” Expert Review of Anticancer Therapy, pp. 1–11, 2015. View at Publisher · View at Google Scholar
  • Håkon Reikvam, Tuyen Thi van Hoang, and Øystein Bruserud, “Emerging therapeutic targets in human acute myeloid leukemia (part 2) – bromodomain inhibition should be considered as a possible strategy for various patient subsets,” Expert Review of Hematology, pp. 1–13, 2015. View at Publisher · View at Google Scholar
  • Hsu-Yu Chen, Wangta Liu, Sung-Yu Wu, Pinwen Peter Chiou, Yen-Hsing Li, Yen-Chun Chen, Gen-Hwa Lin, Ming-Wei Lu, and Jen-Leih Wu, “RIG-I specifically mediates group II type I IFN activation in nervous necrosis virus infected zebrafish cells,” Fish & Shellfish Immunology, 2015. View at Publisher · View at Google Scholar
  • Yu Yang, Bo Yu, and Yun Chen, “Blood disorders typically associated with renal transplantation,” Frontiers in Cell and Developmental Biology, vol. 3, 2015. View at Publisher · View at Google Scholar
  • Olivier Garraud, and Fabrice Cognasse, “Are Platelets Cells? And if Yes, are They Immune Cells?,” Frontiers in Immunology, vol. 6, 2015. View at Publisher · View at Google Scholar
  • Marian Nassef Kadry Naguib Roufaiel, James W. Wells, and Raymond J. Steptoe, “Impaired T-Cell Function in B-Cell Lymphoma: A Direct Consequence of Events at the Immunological Synapse?,” Frontiers in Immunology, vol. 6, 2015. View at Publisher · View at Google Scholar
  • Peter P. Ruvolo, “The Interplay between PP2A and microRNAs in Leukemia,” Frontiers in Oncology, vol. 5, 2015. View at Publisher · View at Google Scholar
  • María J Cejalvo, and Javier de la Rubia, “Front-line lenalidomide therapy in patients with newly diagnosed multiple myeloma,” Future Oncology, pp. 1–16, 2015. View at Publisher · View at Google Scholar
  • Ashley D Staton, Jean L Koff, Qiushi Chen, Turgay Ayer, and Christopher R Flowers, “Next-generation prognostic assessment for diffuse large B-cell lymphoma,” Future Oncology, pp. 1–15, 2015. View at Publisher · View at Google Scholar
  • V.P. Roberto, D.M. Tiago, K. Gautvik, and M.L. Cancela, “Evidence for conservation of miR-223 in zebrafish (Danio rerio): Implications for function,” Gene, 2015. View at Publisher · View at Google Scholar
  • Yang Hu, Qian Xiong, Yadong Yang, Hai Wang, Chang Shu, Wei Xu, Xiangdong Fang, and Songnian Hu, “Integrated analysis of gene expression and microRNA regulation in three leukemia-related lymphoblastic cell lines,” Gene, 2015. View at Publisher · View at Google Scholar
  • C Röger, T Pozzuto, R Klopfleisch, J Kurreck, S Pinkert, and H Fechner, “Expression of an engineered soluble coxsackievirus and adenovirus receptor by a dimeric AAV9 vector inhibits adenovirus infection in mice,” Gene Therapy, 2015. View at Publisher · View at Google Scholar
  • Brian Vadasz, Pingguo Chen, Issaka Yougbaré, Darko Zdravic, June Li, Conglei Li, Naadiya Carrim, and Heyu Ni, “Platelets and platelet alloantigens: Lessons from human patients and animal models of fetal and neonatal alloimmune thrombocytopenia,” Genes & Diseases, 2015. View at Publisher · View at Google Scholar